Summary of project PR001035
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001035. The data can be accessed directly via it's Project DOI: 10.21228/M8X39Q This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Project ID: | PR001035 |
Project DOI: | doi: 10.21228/M8X39Q |
Project Title: | Untargeted metabolomics analysis of A549 cancer cells treated in vitro and in vivo by control (DMSO) or DRB18 |
Project Type: | Untargeted quantitative metabolomics analysis |
Project Summary: | DR18, a novel anticancer compound was used to A549 lung cancer cells in vitro and A549 cell line derived xenograft tumors in vivo in nude mice. The untargeted metabolomics data was generated from these studies. |
Institute: | Ohio University |
Department: | Biological Sciences |
Laboratory: | Dr. Xiaozhuo Chen, Edison biotechnology Institute |
Last Name: | Shriwas |
First Name: | Pratik |
Address: | 172 Water Tower, Building 25, The Ridges, Konnekar Research Centerm Athens Ohio - 45701, USA |
Email: | ps774614@ohio.edu |
Phone: | 740-603-3801 |
Contributors: | Campus Chemical Instrument Center, Ohio State University |
Summary of all studies in project PR001035
Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
---|---|---|---|---|---|---|---|---|
ST001610 | Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours | Homo sapiens | Ohio University | MS | 2020-12-09 | 1 | 18 | Uploaded data (9.3G)* |
ST001638 | Metabolomics analysis of Vehicle (DMSO/PBS; (1:1) v/v) and DRB18 (10 mg/kg) treated A549 xenograft tumors | Mus musculus | Ohio University | MS | 2021-04-01 | 1 | 24 | Uploaded data (1.8G)* |